A review of clinical pharmacogenetics Studies in African populations

F Radouani, L Zass, Y Hamdi, J Rocha… - Personalized …, 2020 - Taylor & Francis
Effective interventions and treatments for complex diseases have been implemented
globally, however, coverage in Africa has been comparatively lower due to lack of capacity …

Genetic variation and sickle cell disease severity: a systematic review and meta-analysis

JK Kirkham, JH Estepp, MJ Weiss… - JAMA network …, 2023 - jamanetwork.com
Importance Sickle cell disease (SCD) is a monogenic disorder, yet clinical outcomes are
influenced by additional genetic factors. Despite decades of research, the genetics of SCD …

An expert review of pharmacogenomics of sickle cell disease therapeutics: not yet ready for global precision medicine

K Mnika, GD Pule, C Dandara… - OMICS: A Journal of …, 2016 - liebertpub.com
Sickle cell disease (SCD) is a blood disease caused by a single nucleotide substitution (T>
A) in the beta globin gene on chromosome 11. The single point mutation (Glu6Val) promotes …

Drug Metabolizing Enzymes: An Exclusive Guide into Latest Research in Pharmaco-genetic Dynamics in Arab Countries

LAL Eitan, IY Khair, S Alahmad - Current Drug Metabolism, 2024 - benthamdirect.com
Drug metabolizing enzymes play a crucial role in the pharmacokinetics and
pharmacodynamics of therapeutic drugs, influencing their efficacy and safety. This review …

Role of GSTM1 in Hypertension, CKD, and Related Diseases across the Life Span

R Levy, TH Le - Kidney360, 2022 - journals.lww.com
Over 20 years after the introduction of angiotensin-converting enzyme inhibitors and
angiotensin receptor blockers, CKD remains a major public health burden with limited …

Genetic factors modifying sickle cell disease severity

K Gardner, SL Thein - Sickle cell anemia: From basic science to clinical …, 2016 - Springer
Sickle cell disease (SCD) is a monogenic disorder caused by a single base mutation but
despite its apparent genetic simplicity, the clinical phenotype is hugely variable. In addition …

GSTT1 (rs4025935) null genotype is associated with increased risk of sickle cell disease in the populations of Tabuk—Northwestern region of Saudi Arabia

F Abu-Duhier, R Mir - Hematology, 2017 - Taylor & Francis
Background: Glutathione system plays an important role in the protection of cells and tissue
against damage from oxidative stress. Impairment of the glutathione system due to genetic …

[HTML][HTML] Evaluation of glutathione-S-transferase P1 polymorphism and its relation to bone mineral density in Egyptian children and adolescents with beta-thalassemia …

SM Ragab, EA Badr, AS Ibrahim - Mediterranean Journal of …, 2016 - ncbi.nlm.nih.gov
Background Osteoporosis is a major complication of beta thalassemia major (TM). Increased
oxidative stress and its controlling genes were linked to osteoporosis. Ile105 Val variant is a …

Coexpression network analysis of platelet genes in sickle cell disease

FF Liu, TT Tu, HF Zhang, F Hu, L Huang, LF Deng… - Platelets, 2019 - Taylor & Francis
Platelets play important roles in vascular health. Activation of platelet may contribute to
coagulation and inflammation. Evidence suggests circulating platelets are chronically …

Key pharmacogenomic considerations for sickle cell disease patients

A Kolliopoulou, A Stratopoulos… - OMICS: A Journal of …, 2017 - liebertpub.com
Sickle cell disease (SCD), although a monogenic disease, exhibits a complex clinical
phenotype that hampers optimum patient stratification and disease management, especially …